About
Technology
Issues
FAQ
Search
filter by year
2024 (6,198)
2023 (109,109)
2022 (346,563)
2021 (393,512)
2020 (349,520)
2010-2019 (1,943,733)
2000-2009 (713,034)
1990-1999 (338,351)
1980-1989 (167,987)
1970-1979 (88,582)
1960-1969 (46,624)
1950-1959 (22,306)
1900-1950 (39,480)
Similar Keywords
work study (329)
study (4,733,026)
1-20 of (4,733,299 documents found)
2011
554
Recent progress in the diagnosis and treatment of ovarian cancer
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 61, 183-203.
Cite
Citations
Matthew Li (80, 6.9K)
2014
393
MicroRNAome genome: A treasure for cancer diagnosis and therapy
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 64, 311-336.
Cite
Citations
Matthew Li (80, 6.9K)
2017
225
Lung cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 67, 138-155.
Cite
Citations
Matthew Li (80, 6.9K)
2021
59
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 71, 437-454.
Cite
Citations
Matthew Li (80, 6.9K)
2008
150
The Staging of Cancer: A Retrospective and Prospective Appraisal
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 58, 180-190.
Cite
Citations
Matthew Li (80, 6.9K)
2019
0
Study evaluates mobile telephone interventions for socioeconomically disadvantaged smokers
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 69, 164-165.
Cite
Citations
Matthew Li (80, 6.9K)
2016
0
Study suggests it is safe to ease neutropenic restrictions
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 66, 441-442.
Cite
Citations
Matthew Li (80, 6.9K)
2008
2
STUDY QUANTIFIES RISK OF BREAST CANCER RECURRENCE
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 58, 322-322.
Cite
Citations
Matthew Li (80, 6.9K)
2006
0
STUDY CONFIRMS SURVIVAL BENEFIT FROM ADJUVANT RADIATION FOR BREAST CANCER
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 56, 133-134.
Cite
Citations
Matthew Li (80, 6.9K)
2005
0
STUDY: VITAMIN E NO OVERALL HELP AGAINST CANCER
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 55, 205-206.
Cite
Citations
Matthew Li (80, 6.9K)
2003
0
STUDY SUGGESTS NICOTINE MAY PROMOTE CANCER DEVELOPMENT
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 53, 66-67.
Cite
Citations
Matthew Li (80, 6.9K)
2002
1
ESTROGEN/PROGESTIN HORMONE REPLACEMENT THERAPY RISKS OUTWEIGH BENEFITS: STUDY STOPPED EARLY DUE TO EXCESS BREAST CANCER, HEART DISEASE
Ca-A Cancer Journal for Clinicians
(
157.7
★★★
), 52, 248-249.
Cite
Citations
Matthew Li (80, 6.9K)
2017
19.4K
Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Kidney and Blood Pressure Research
(
0.9
★★★
), 42, 33-42.
Cite
Citations
Matthew Li (80, 6.9K)
2018
2.3K
Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014
MMWR Surveillance Summaries
(
18.6
★★★
), 67, 1-23.
Cite
Citations
Matthew Li (80, 6.9K)
2011
8.1K
Metagenomic biomarker discovery and explanation
Genome Biology
(
13.9
★★★
), 12, R60.
Cite
Citations
Matthew Li (80, 6.9K)
2008
10.7K
Sorafenib in Advanced Hepatocellular Carcinoma
New England Journal of Medicine
(
13.9
★★★
), 359, 378-390.
Cite
Citations
Matthew Li (80, 6.9K)
2020
5.8K
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
Lancet, The
(
6.3
★★★
), 395, 514-523.
Cite
Citations
Matthew Li (80, 6.9K)
2016
1.3K
Chemical, thermal and mechanical stabilities of metal–organic frameworks
Nature Reviews Materials
(
23.3
★★★
), 1, .
Cite
Citations
Matthew Li (80, 6.9K)
2014
5.4K
Biological insights from 108 schizophrenia-associated genetic loci
Nature
(
13.7
★★★
), 511, 421-427.
Cite
Citations
Matthew Li (80, 6.9K)
2012
6.2K
Comprehensive molecular characterization of human colon and rectal cancer
Nature
(
13.7
★★★
), 487, 330-337.
Cite
Citations
Matthew Li (80, 6.9K)
1
2
3
site/software ©
exaly
; All materials licenced under
CC by-SA
.